Cargando…
Mesothelin-targeted CAR-T cells for adoptive cell therapy of solid tumors
Significant progresses have been made in adoptive cell therapy with CAR-T cells for cancers, especially for hematological malignancies. However, the treatment of solid tumors still poses a tremendous challenge and remains an unmet medical need. Several factors are held responsible for the inadequate...
Autores principales: | Zhang, Gui-Zhen, Li, Tian-Fang, Han, Shuang-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425252/ https://www.ncbi.nlm.nih.gov/pubmed/34522250 http://dx.doi.org/10.5114/aoms.2019.84888 |
Ejemplares similares
-
The antitumor capacity of mesothelin-CAR-T cells in targeting solid tumors in mice
por: Zhang, Qian, et al.
Publicado: (2021) -
Mesothelin-targeted second generation CAR-T cells inhibit growth of mesothelin-expressing tumors in vivo
por: Ye, Lin, et al.
Publicado: (2019) -
Challenges of Anti-Mesothelin CAR-T-Cell Therapy
por: Zhai, Xuejia, et al.
Publicado: (2023) -
Combination Strategies to Improve Targeted Radionuclide Therapy
por: Chan, Tiffany G., et al.
Publicado: (2020) -
Allogeneic Hematopoietic Cell Transplantation and Cellular Therapy
por: Kim, Hee-Je, et al.
Publicado: (2021)